AXA S.A. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
AXA S.A. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2024$4,368,469
-24.8%
638,665
+0.1%
0.01%
-23.5%
Q1 2024$5,808,576
+2.0%
638,305
-50.0%
0.02%
+88.9%
Q4 2023$5,692,084
+183.6%
1,276,252
+99.7%
0.01%
+28.6%
Q3 2023$2,007,195
-18.1%
639,234
+34.6%
0.01%
-12.5%
Q2 2023$2,450,484474,9000.01%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders